BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 18, 2013
View Archived Issues
Serum albumin binding proteins developed at Ablynx
Read More
Serine racemase knockout mice show decreased susceptibility to seizures
Read More
Pharma Bio partners timodepressin in Russia
Read More
NanoSmart and UCLA collaborate on new drug delivery platform
Read More
Innate Pharma presents phase I results for their anti-KIR antibody in AML
Read More
Novel radiotracers for imaging tau pathology evaluated
Read More
New antineoplastic agents synthesized at Pharminox
Read More
French researchers disclose new monoclonal antibodies for cancer and other disorders
Read More
ArQule patents new protein kinase inhibitors for cancer
Read More
Enrollment in phase II GMI-1070 trial in sickle cell disease completed
Read More
Novel thrombin inhibitors divulged by Chinese researchers
Read More
Iluvien receives marketing approval for chronic diabetic macular edema in Spain
Read More
Scientists at Kissei Pharmaceutical synthesize new SGLT2 inhibitors
Read More
Xencor receives milestone payment from Janssen for Xtend antibody
Read More
Boehringer Ingelheim enrolls patients in phase III HCVerso program
Read More
Medicago signs loan agreement with major pharmaceutical company
Read More
Siemens presents early clinical results for [18F]-T-807
Read More
Kyorin and Daiichi Sankyo terminate imidafenacin agreement in Brazil
Read More
Emergent BioSolutions begins phase II trial of NuThrax anthrax vaccine
Read More
Data and safety monitoring board clears way to completion for SyNAPSe trial
Read More
European CHMP hands down negative opinion for Raxone MAA
Read More
FDA approves first patch for treatment of migraine
Read More
European CHMP set to discuss MAA for defibrotide
Read More
Omeros' CRA technology identifies small molecules for Class B GPCR
Read More
Phase I study of KPT-330 opens to patients with AML
Read More